Shekhar Natarajan Msc Frsc Ftopra

Shekhar Natarajan MSc FRSC FTOPRA is a seasoned professional in regulatory affairs with extensive experience across multiple renowned pharmaceutical organizations. Currently serving as a member of the Therapies Scientific Committee and the Regulatory Task Force for the International Rare Diseases Research Consortium since February 2025, and as a Med Chem Expert Advisory Group Member at The British Pharmacopoeia since January 2024. Shekhar is also the Vice President, Head of EU and International Regulatory Affairs at Dyne Therapeutics, a position held since January 2023. Previous roles include Executive Director at GW Pharmaceuticals, Head of International Regulatory Strategy at Shire, Director of Global Regulatory Affairs & Quality Assurance at Merck Serono, and Associate General Manager at Biocon Limited. Earlier career experiences include Regulatory Project Lead at Johnson & Johnson (UK), Global Regulatory Affairs at GlaxoSmithKline Pharmaceuticals, and Senior Scientist-R&D at UCB Celltech. Shekhar holds a Master's degree in Pharmaceutical Sciences from the University of Greenwich.